Predictors of self-management in pediatric type 1 diabetes: individual, family, systemic, and technologic influences

Diana Naranjo1, Shelagh Mulvaney, Maureen McGrath

  • 1University of California, 3333 California St. Suite 245, Box 0503, San Francisco, CA, 94118, USA, NaranjoD@peds.ucsf.edu.

Current Diabetes Reports
|September 10, 2014
PubMed

Insights

Effective self-management is key for children and adolescents with type 1 diabetes (T1D). Individual, family, and systemic factors all impact T1D management, guiding future interventions.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Behavioral Science

Background:

  • Type 1 diabetes (T1D) is a chronic condition requiring lifelong self-management.
  • The responsibility for T1D management significantly impacts individuals and families.
  • Successful T1D self-management is crucial for long-term health outcomes in youth.

Purpose of the Study:

  • To explore individual, family, and systemic/technologic factors influencing T1D self-management.
  • To review research supporting interventions for T1D self-management.
  • To enhance understanding of T1D self-management for healthcare providers and researchers.

Main Methods:

  • Literature review of factors affecting T1D self-management.
  • Analysis of research on interventions targeting self-management.
  • Synthesis of information for clinical and research application.

Main Results:

  • Identified key individual, family, and systemic/technologic influences on T1D self-management.
  • Highlighted evidence-based interventions for improving T1D self-management.
  • Demonstrated the multifaceted nature of T1D self-management.

Conclusions:

  • Individual, family, and systemic factors are critical determinants of T1D self-management success.
  • Targeted interventions can bolster T1D self-management in pediatric populations.
  • Improved understanding of these factors can advance T1D care and research.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
26
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
Stress Prevention and Stress Management Techniques I01:26

Stress Prevention and Stress Management Techniques I

Stress prevention and management are crucial for maintaining well-being and building resilience. Techniques to manage stress include cultivating qualities like conscientiousness, a sense of personal control, and self-efficacy. Each of these traits significantly reduces stress and promotes healthier lifestyle choices and outcomes.
Conscientiousness
Conscientious individuals tend to be organized, responsible, and disciplined. They prioritize completing tasks and following structured routines,...
493